T. Rowe Price Investment Management, Inc. Immunocore Holdings PLC Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,992,273 shares of IMCR stock, worth $94 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,992,273
Previous 733,611
307.88%
Holding current value
$94 Million
Previous $47.7 Million
112.66%
% of portfolio
0.06%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
150Shares Held
39.8MCall Options Held
157KPut Options Held
135K-
Wellington Management Group LLP Boston, MA6.38MShares$200 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$153 Million2.76% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$88.9 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$61.3 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY1.52MShares$47.6 Million0.68% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.38B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...